Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Elicityl is a French biotechnology company specializing in the production and engineering of complex carbohydrates and glycoconjugates. Through its proprietary Oligotech platform, the company provides a comprehensive library of oligosaccharides and offers custom synthesis services for pharmaceutical, cosmetic, and diagnostic applications. Elicityl focuses on the role of glycans in biological recognition, developing glyco-based solutions for therapeutic areas such as inflammation, oncology, and infectious diseases. The company operates both as a high-tech service provider (CRO) and as a developer of its own internal pipeline of glyco-drug candidates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Elicityl Oligotech.